Answers - Finance

Invest in high risk investments and receive high yields. Invest in low risk stocks or funds and receive lower yields. It is a standard investing maxim. But ‘risk’ is the operative word and there are no guarantees in eithe

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

r class. The key to success is not simply sticking your money into a high risk investment and hope for the best. High yields investments require that you take into account several factors and research is key.

If you take

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

the time to do your homework, you can reduce the risk in high risk investments and maximize yields.

In reality, most high risk investments will potentially fail to make you the money you expect and return disappointing

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

yields. And this is usually not because of trading conditions but due to poor managers. The markets are a relatively flat playing area, so all asset managers start from the same position. Yet most fail while others excel.

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

It is a fact that most mutual, future and hedge funds produce poor returns.

So what can you do to ensure that your investment constantly yield high returns? You are taking the risk with your money. How do you protect yo

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

ur investment and receive the rewards you would expect from your risk?

First of all check the consistency of performance of the investment. Any investment can have a period o high performance in a bull market. A short bu

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

rst of high yields might be down to a specific market issue, a spike in one sector or generally strong trend. To take out the short term success factor look at the investment over a three to five year period. If yields ar

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

e consistent and if they performed well in market downturns then these are the sort of vehicles worth your time. They will show that steady management has kept these investments returning good yields over a long period.

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

A second area to look at is fees. Make sure when you are reviewing yields that you look at fees and how they may impact returns. Fees can quickly add up and they can serious reduce your returns. And remember it’s you taki

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

ng the risk.

Managers who get paid a portion of the trading fees could be in a conflict of interest between generating revenue for the fund or institution and what’s best for you. Mangers in this situation are more likel

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

y to trade in order to create more commissions for themselves and that might not be best for the investment.

Thirdly look at the performance of the manager. Look at his or her performance with all funds they have managed

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

. Some asset managers will show off their best performing account but it is incumbent upon you to look at all their investments. And again look over a longer period of time. If the fund manager has been successful with a

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

number of investment vehicles over three to five years through a number of market conditions then they are worthy of your confidence.

The best managers will use long term disciplined techniques that liquidate losers quic

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

kly and ride profitable trends. If you are risking your money in high yielding investments that are designed to produce higher returns then the method of trading is crucial. You have to have confidence in the manger that

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

that will stick with their system or manage their way out of losing periods. Drawdowns are important to look at too. Drawdowns are the peak-to-trough decline during a specific period of an investment or fund. It is usual

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

ly quoted as the percentage between the peak and the trough. A drawdown is from the time a retrenchment begins to when a new high is reached (because you won't know the depth of the trough until the new high is reached).

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

It is important to look at your investment in terms of drawdown as well as profit and look at the performance in terms of the severity and length of any drawdown.

For example, if an asset manager produces gains of 60 per

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

cent with a 50 percent drawdown and another does 40 percent with a 15 percent drawdown, the latter is probably the better from a risk over reward point of view.

Another thing to consider is the length of a drawdown from

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

peak to valley. If you jumped in at a particularly low period for the investment, how long would it take for you to reach a new high in equity?

As with so many investments research is key. But the higher risk of high yie

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

ld investments means you have more things to consider and must research more and deeper into the investment and the manger. If you follow the above you can go some way to minimizing your risks and maximizing your profits.

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.answers.org.ua/article/102619/answers-Research-Key-to-High-Yield-Investments.html">Research Key to High Yield Investments</a>

BB link (for phorums):
[url=http://www.answers.org.ua/article/102619/answers-Research-Key-to-High-Yield-Investments.html]Research Key to High Yield Investments[/url]

Get more sales by using the most effective, yet overlooked marketing strategy in existence for small business owners and professionals...

Certification training videos are aimed at helping persons acquire a recognized validation of the skills/learning that they will acquire upon successful completion of the various levels/learning modules presented in the video.

You're in kind of a bind. The money's really getting tight. What can you do? Well, there are many things. Maybe you can ask your boss for a raise, but it's not bloody likely you'll get one! Is a debt consolidation loan the answer? Maybe or maybe not.

Tags

Links

Answers - Research Key to High Yield Investments

Related Articles: